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were expressed at low levels, while Col1a1, VEGF and alpha11
integrin were highly expressed together with TIMP-1, TIMP-2
and MMP-13. Upon osteogenic and chondrogenic differentiation
these genes were differentially regulated. Cytokine and growth
factor profile was assessed at protein level using an antibody ar-
ray. Here, we observed secretion of TIMP-1, MCP-1, VEGFα-165,
while CINC-2 and β-NGF were detected intracellulary. This ex-
pression profile was dependent on differentiation state of MSCs
while other factors embedded into the array could not be detected
irrespective of culture conditions.
Conclusions: Our gene expression results provide a founda-
tion for a more reproducible and reliable quality control of rat
bone marrow derived MSCs used for osteo-chondrogenic dif-
ferentiation studies. Additionally, we demonstrate secretion and
production of cytokines and growth factors from a heteroge-
neous BM cell population which may be crucial for MSCs fate
determination and sustenance.
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CRYOPRESERVED WITH THE NATURAL
GLYCOSYLATED HYDROQUINONE, ARBUTIN
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Purpose: Chondrocytes are essential to maintain the integrity of
the articular cartilage matrix. Freezing of intact articular cartilage,
even in the presence of cryoprotective agents, like glycerol or
dimethyl sulfoxide, seriously compromises the viability of chon-
drocytes and, thus, the integrity and durability of cryopreserved
osteochondral allografts used to repair several types of cartilage
deffects. This study aims at evaluating the ability of the natural
glycosylated hydroquinone, Arbutin, to protect articular chondro-
cytes from the damaging effects of freeze/thawing, using human
tibial plateaus as a model of osteochondral allografts.
Methods: Tibial plateaus were harvested from cadaver tissue
donors within 24 hours of death, in strictly aseptic conditions
according to the standards of the Tissue and Bone Bank of the
University Hospital of Coimbra, Portugal, and the Portuguese
Transplantation Organization. Donor age ranged from 17 to 53
years old. Articular cartilage from all donors appeared grossly
normal without signs of fibrillation or other lesions. The lateral
and medial tibial plateaus from each cadaver tissue donor were
incubated in Ham F-12 Nutrient Mixture with or without arbutin
(50 or 100 mM) for 30 minutes to 1 hour at 37°C and then
frozen at -20°C/24h. After the initial cooling, the osteochondral
pieces were transferred to a biofreezer at -80°C and kept in those
conditions for a maximum of 2 months. Thawing was achieved
by immersion in Ham F-12 Nutrient Mixture at 37°C for 1h.
Chondrocyte viability was assessed in situ by a modification of
the MTT reduction assay and by staining cryostat sections with
Calcein AM and Propidium Iodide. Where applicable, statistical
analysis was performed using the Student’s t test. Results were
considered significant for p<0.05.
Results: Chondrocyte viability in the osteochondral pieces im-
mediately before freezing, was identical in all the conditions
tested. After freeze/thawing, chondrocyte viability, expressed as
the percent MTT reduction relatively to the viability of chondro-
cytes in fresh cartilage, was significantly higher in tibial plateaus
treated with arbutin than in those treated with the nutrient mix-
ture alone (Control), as shown in table 1. However, fluorescence
microscopy showed that living chondrocytes were restricted to
the superficial cartilage layers.
Results are the mean ± SE of 4 different experiments, each
performed in duplicate.
Table 1. Chondrocyte viability in freeze/thawed cartilage relatively to the fresh
tissue
Control Arbutin, Arbutin, Arbutin,
50mM, 30 min 50mM, 1h 100mM, 30 min
11.1 ± 9.4 32.0 ± 10.8 34,2 ± 2.9 28,5 ± 6.2
Conclusions: The results presented indicate that Arbutin is a low
toxicity cryoprotective agent that effectively preserves chondro-
cyte viability, at least, in the superficial cartilage layers. Neverthe-
less, further studies are required to identify conditions of cryop-
reservation with this natural compound that allow the protection
of chondrocytes in the entire depth of the articular cartilage,
which is essential to maintain cartilage integrity in cryopreserved
osteochondral allografts.
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Purpose: Osteoarthritis (OA) as the most prevalent disorder of
the musculoskeletal system is a consequence of mechanical
and biological events destabilizing tissue homeostasis in articu-
lar joint tissues. Thus, it involves the disturbance in the normal
balance of degradation and repair in articular cartilage, synovial
membrane and subchondral bone. Current means and surgical
procedures for an efficient treatment are restricted to symp-
tomatic measures or are quite unsatisfactory in the long-term
evaluation. Tissue Engineering (TE) provides new sustainable
therapy strategies based on the transplantation of cells as sus-
pensions or in combination with scaffolds to the defect side.
Mesenchymal progenitor cells like mesenchymal stem cells and
periosteal progenitor cells meet the demands of regenerating
complex defects like articular knee cartilage and the underlying
bone occurring due OA progression.
Since several years we investigate the regenerative properties
of periosteal progenitor cells. In a new approach we developed
three-dimensional (3D) cell culture techniques comprising the
use of periosteal progenitor cells mixed with fibrinogen and em-
bedded in PGLA biomaterials to allow the formation of osseous
and cartilaginous tissue in vitro and in animal models. The aim of
this study was to characterize human cartilage and bone tissue
engineering on the molecular level.
Methods: With regard to a possible translation into the clinic,
we performed the experiments in a clinically applicable setting:
Human periosteal cells from mastoid (n=3) were isolated and
cultured in complete DME-medium containing human serum.
Passage 3 cells were mixed with human fibrinogen, embed-
ded in PGLA fleeces and induced according to osteogenic or
chondrogenic standard protocols.
Results: After one, two and four weeks of osteogenic induction
the formation of mineralized bone matrix was shown by von
Kossa staining. Chondrogenic differentiation was demonstrated
by collagen type II immunohistochemistry and by alcian blue
staining after two, four and six weeks of induction. Cell viability
was investigated by using PI/FDA staining. RNA from culture
expanded periosteal progenitor cells, 3D bone grafts (timepoint:
7, 14 and 28 days), native bone, 3D cartilage graft (timepoint:
14, 28 and 42 days) and native cartilage were used for genom-
wide gene expression profiling analysis using the Affymetrix HG
U133 plus 2.0 oligonucleotid microarray. The analysis by pat-
tern discovery displayed the regulation of distinct genes already
described as relevant in osteogenesis and chondrogenesis, like
genes involved in matrix formation, and also of possible new
marker genes.
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Conclusions: 3D tissue culture of expanded human mastoid-
derived periosteal progenitor cells in resorbable PGLA fleeces
initiates bone and cartilage formation on the cellular and molecu-
lar level. The generation of different mesenchymal tissue makes
3D tissue cultured periosteal progenitor cells to promising can-
didates for the treatment of OA. Further investigations with pe-
riosteal progenitor cells from donors with OA were necessary for
an autologous therapy strategy.
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Purpose: The use of autologous chondrocytes seeded onto a bi-
ological scaffold represent a current valid tool for cartilage repair.
However, the effect of the contact of the blood to the engineered
construct is unknown. The aim of this work was to investigate the
effect of blood contact on the morphological, biochemical and
biomechanical properties of engineered cartilage.
Methods: Articular chondrocytes were enzymatically isolated
from swine joints, expanded in monolayer culture and seeded
onto collagen membranes for two weeks. Peripheral blood was
obtained from animals of the same spices. The cell-seeded col-
lagen membranes were placed in contact with the blood, diluted
with medium, for three days ("blood" group). As controls ("control"
group), some samples were left in medium, with no blood con-
tact. Some samples were retrieved from cultures after the blood
contact, some others were left in standard culture conditions for
3 more weeks. Samples were analysed grossly, histologically,
biochemically (MTT analysis), and by biomechanical analysis
under unconfined geometry.
Results: Upon retrieval, samples from both groups showed in-
creasing dimensions and weights overtime, with higher mean val-
ues recorded for control group. Biochemical evaluation demon-
strated a transient reduction of the mitochondrial activity due
to blood contact. Histological evaluation demonstrated evident
cartilage-like matrix production for both groups. Biomechanical
data showed a reduction of the values in the early culture time,
followed by a stabilization regardless the presence of the blood.
Conclusions: The results obtained from this study demonstrate
that the contact to blood of the samples determine a transient re-
duction of the mitochondrial activity. However, the morphological
parameters seem to show a continue production of the cartilage
matrix components overtime. This tissue engineered cartilage
structure is easily reproducible and it could represent a valuable
model for studying the behaviour of different variables on the
newly formed cartilage.
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NEW TISSUE GROWTH AFTER COLLAGEN MENISCUS
IMPLANT (CMI) PLACEMENT INCREASES ACTIVITY
LEVELS AFTER TWO YEARS
W.G. Rodkey, K.K. Briggs
Steadman Hawkins Research Foundation, Vail, CO
Purpose: Absence of meniscus tissue leads to decreased clin-
ical function and activity levels. In a previous study, we re-
ported significant correlation between actual measured amounts
of meniscus tissue removed at meniscectomy and symptoms,
function and activity 2 years after surgery. In particular, it was
noteworthy that patients with >50% remaining meniscus tissue
were significantly better in all categories measured than patients
with <50% total meniscus tissue remaining. The purpose of the
present study was to determine, prospectively, changes in Teg-
ner activity levels from preoperative to 2 years postoperative in
patients who received Collagen Meniscus Implants (CMI) and
were documented to have >50% total meniscus tissue at 1-year
relook arthroscopy.
Methods: In a randomized controlled investigational device clin-
ical trial (Level of Evidence I), 138 patients 18 to 60 years old
underwent partial medial meniscectomy and placement of a CMI
to fill the meniscus defect. There were 64 acute (no prior menis-
cus surgery) and 74 chronic (1 to 3 prior partial meniscectomies
on the involved meniscus) patients. At index surgery, meniscus
defect size was measured with specially designed instruments,
and the percent of meniscus loss was calculated based on these
actual measurements. Relook arthroscopy was performed at 1
year on 124 patients (90% surgical follow-up), and percent to-
tal meniscus tissue (remnant + new tissue) was determined by
making these same measurements and calculations. Patients
were followed clinically for a minimum of 2 years after CMI place-
ment. At each follow-up, all patients completed questionnaires,
including a Tegner score to assess activity. We then determined
changes in Tegner score from the index surgery to 2 years status
post CMI in these patients.
Results: Of 124 relooks, 111 patients (90%) had >50% total
meniscus tissue. In these patients, average Tegner activity scores
improved by two levels from 3 to 5 from preoperative to 2
years status post CMI. This increased change in activity levels
significantly correlated with total meniscus tissue >50% (r=0.21,
p=0.02). These findings mirrored those we previously reported
for partial meniscectomy patients in which >50% of the meniscus
was maintained.
Conclusions: There is a significant correlation between change
(increase) in Tegner activity levels over 2 years and percent total
meniscus tissue in patients who receive the CMI as treatment
for meniscus loss and have >50% total meniscus tissue. This
study confirms the importance of preserving as much meniscus
tissue as possible at the time of repair or meniscectomy. It
clearly supports the potential positive benefits of regrowing or
regenerating lost meniscus tissue to assist patients in regaining
their activity.
P389
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Purpose: Osteoarthritis (OA) is such a widespread complication
of old age that it is expected to become the fourth leading
cause of disability by the year 2020. As a hallmark of the
pathogenesis of late stages of the disease, in addition to the
diseased chondrocytes (type 1 cells), type 2 cells emerge. While
